Telithromycin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Telithromycin" in English language version.

refsWebsite

Global rank English rank

6nih.gov

4^th place

4web.archive.org

1^st place

3doi.org

2^nd place

3fda.gov

447^th place

338^th place

2wsj.com

79^th place

65^th place

1books.google.com

3^rd place

1harvard.edu

18^th place

17^th place

1house.gov

529^th place

314^th place

1nytimes.com

7^th place

books.google.com (Global: 3^rd place; English: 3^rd place)

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 499. ISBN 9783527607495.

doi.org (Global: 2^nd place; English: 2^nd place)

Clay KD, Hanson JS, Pope SD, Rissmiller RW, Purdum PP, Banks PM (March 2006). "Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review". Annals of Internal Medicine. 144 (6): 415–420. doi:10.7326/0003-4819-144-6-200503210-00121. PMID 16481451.
Bertrand D, Bertrand S, Neveu E, Fernandes P (December 2010). "Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors". Antimicrobial Agents and Chemotherapy. 54 (12): 5399–5402. doi:10.1128/aac.00840-10. PMC 2981250. PMID 20855733.
Eyal Z, Matzov D, Krupkin M, Wekselman I, Paukner S, Zimmerman E, et al. (October 2015). "Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus". Proceedings of the National Academy of Sciences of the United States of America. 112 (43): E5805–E5814. Bibcode:2015PNAS..112E5805E. doi:10.1073/pnas.1517952112. PMC 4629319. PMID 26464510.

fda.gov (Global: 447^th place; English: 338^th place)

Brinker A (December 2006). "Telithromycin-Associated Hepatotoxicity". U.S. Food and Drug Administration. Archived from the original on 2017-05-17. Retrieved 2019-12-16.
Ball L (18 May 2006). "Notice of Initiation of Disqualification Proceedings and Opportunity to Explain (Nidpoe)". U.S. Food and Drug Administration. Archived from the original on September 30, 2006.
"FDA Announces Label and Indication Changes for the Antibiotic Ketek". Food and Drug Administration. Archived from the original on 2007-02-14.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Eyal Z, Matzov D, Krupkin M, Wekselman I, Paukner S, Zimmerman E, et al. (October 2015). "Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus". Proceedings of the National Academy of Sciences of the United States of America. 112 (43): E5805–E5814. Bibcode:2015PNAS..112E5805E. doi:10.1073/pnas.1517952112. PMC 4629319. PMID 26464510.

house.gov (Global: 529^th place; English: 314^th place)

energycommerce.house.gov

"The House Committee on Energy and Commerce :: Hearing". Archived from the original on 2007-04-26. Retrieved 2007-04-20. House of Representatives, The House Committee on Energy and Commerce, Honorable John D. Dingell, Chairman, Subcommittee on Oversight and Investigations, "The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply", February 13, 2007.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Clay KD, Hanson JS, Pope SD, Rissmiller RW, Purdum PP, Banks PM (March 2006). "Brief communication: severe hepatotoxicity of telithromycin: three case reports and literature review". Annals of Internal Medicine. 144 (6): 415–420. doi:10.7326/0003-4819-144-6-200503210-00121. PMID 16481451.
Bertrand D, Bertrand S, Neveu E, Fernandes P (December 2010). "Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors". Antimicrobial Agents and Chemotherapy. 54 (12): 5399–5402. doi:10.1128/aac.00840-10. PMC 2981250. PMID 20855733.
Eyal Z, Matzov D, Krupkin M, Wekselman I, Paukner S, Zimmerman E, et al. (October 2015). "Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus". Proceedings of the National Academy of Sciences of the United States of America. 112 (43): E5805–E5814. Bibcode:2015PNAS..112E5805E. doi:10.1073/pnas.1517952112. PMC 4629319. PMID 26464510.
Scheinfeld N (2004). "Telithromycin: a brief review of a new ketolide antibiotic". Journal of Drugs in Dermatology. 3 (4): 409–413. PMID 15303785.

ncbi.nlm.nih.gov

Bertrand D, Bertrand S, Neveu E, Fernandes P (December 2010). "Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors". Antimicrobial Agents and Chemotherapy. 54 (12): 5399–5402. doi:10.1128/aac.00840-10. PMC 2981250. PMID 20855733.
Eyal Z, Matzov D, Krupkin M, Wekselman I, Paukner S, Zimmerman E, et al. (October 2015). "Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus". Proceedings of the National Academy of Sciences of the United States of America. 112 (43): E5805–E5814. Bibcode:2015PNAS..112E5805E. doi:10.1073/pnas.1517952112. PMC 4629319. PMID 26464510.

nytimes.com (Global: 7^th place; English: 7^th place)

Harris G (2006-07-19). "Approval of Antibiotic Worried Safety Officials". New York Times. Retrieved 2010-05-25.

web.archive.org (Global: 1^st place; English: 1^st place)

Brinker A (December 2006). "Telithromycin-Associated Hepatotoxicity". U.S. Food and Drug Administration. Archived from the original on 2017-05-17. Retrieved 2019-12-16.
"The House Committee on Energy and Commerce :: Hearing". Archived from the original on 2007-04-26. Retrieved 2007-04-20. House of Representatives, The House Committee on Energy and Commerce, Honorable John D. Dingell, Chairman, Subcommittee on Oversight and Investigations, "The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply", February 13, 2007.
Ball L (18 May 2006). "Notice of Initiation of Disqualification Proceedings and Opportunity to Explain (Nidpoe)". U.S. Food and Drug Administration. Archived from the original on September 30, 2006.
"FDA Announces Label and Indication Changes for the Antibiotic Ketek". Food and Drug Administration. Archived from the original on 2007-02-14.

wsj.com (Global: 79^th place; English: 65^th place)

online.wsj.com

Mathews AW (May 2006). "Fraud, Errors Taint Key Study Of Widely Used Sanofi Drug - WSJ". Wall Street Journal.

wsj.com

[1] Infected Data: Fraud, Errors Taint Key Study Of Widely Used Sanofi Drug Despite Some Faked Results, FDA Approves Antibiotic; One Doctor's Cocaine Use; Company Defends Safety, By ANNA WILDE MATHEWS, Wall Street Journal, May 1, 2006

Telithromycin (English Wikipedia)

books.google.com (Global: 3rd place; English: 3rd place)

doi.org (Global: 2nd place; English: 2nd place)

fda.gov (Global: 447th place; English: 338th place)

harvard.edu (Global: 18th place; English: 17th place)